Soon after infection, poliovirus (PV) shuts off host-cell transcription, which is catalysed by all three cellular RNA polymerases. rRNA constitutes more than 50 % of all cellular RNA and is transcribed from rDNA by RNA polymerase I (pol I). Here, evidence has been provided suggesting that both pol I transcription factors, SL-1 (selectivity factor) and UBF (upstream binding factor), are modified and inactivated in PV-infected cells. UBF were depleted in PV-infected cells and their disappearance correlated with pol I transcription inhibition. rRNA synthesis from a template containing a human pol I promoter demonstrated that both SL-1 and UBF were necessary to restore pol I transcription fully in PV-infected cell extracts. These results suggested that both SL-1 and UBF are transcriptionally inactivated in PV-infected HeLa cells.
INTRODUCTION
Poliovirus (PV) is the type species of a large group of medically important viruses (picornaviruses), including those inducing infectious hepatitis (hepatitis A virus), the common cold (rhinoviruses) and encephalitis and myocarditis (coxsackieviruses). The single-stranded, positivepolarity RNA genome (~7500 nt) of PV (Kitamura et al., 1981; Racaniello & Baltimore, 1981) is translated into one large polyprotein, which is processed co-translationally by the virally encoded proteases 2A pro , 3C pro and 3CD pro into mature viral structural and non-structural proteins. The viral proteases have been studied extensively and found to be highly specific in their polyprotein cleavage: 3C pro and 3CD pro cleave the polyprotein at glutamine-glycine (QG) sites, whilst 2A
pro cleaves only at tyrosine-glycine (YG) bonds (Krausslich & Wimmer, 1988) . The proteases do not cleave every potential cleavage site within the polyprotein; other determinants, such as accessibility and context of the cleavage site, are also important.
Accurate initiation from the rDNA promoter requires two factors in addition to pol I: the upstream binding factor (UBF) and the selectivity factor (SL-1). UBF (Jantzen et al., 1990 ), a sequence-specific DNA-binding protein, interacts with two regions of the template rDNA: the upstream control element, located between nt 2200 and 2170 on the rDNA, and the core promoter element, located between nt +20 and 245 relative to the site of transcription initiation. Human UBF consists of two different polypeptides of 97 and 94 kDa. The 94 kDa form results from a 37 aa deletion due to differential splicing. UBF is known to activate rDNA transcription by recruiting pol I to the rDNA promoter, stabilizing binding of SL-1 and competing with non-specific DNA-binding proteins, such as histone H1 (Kuhn & Grummt, 1992; Kuhn et al., 1993) . SL-1, a protein complex containing the TATA-binding protein (TBP) and three pol I-specific TBP-associated factors (TAFs), TAF 48 , TAF 63 and TAF 110 (Comai et al., 1992) , confers promoter specificity. The TBP subunit of SL-1 does not bind to DNA, and promoter recognition is carried out by the associated TAFs. Both UBF and SL-1 activities are regulated, at least in part, by phosphorylation during the M and G 1 phases (Grummt, 2003) .
Infection of HeLa cells with PV causes a severe decrease in cellular transcription catalysed by all three cellular RNA polymerases . Both biochemical and genetic evidence has shown that the viral protease 3C pro is responsible for pol I transcription shut-off by PV (Weidman et al., 2003) . Our studies have also shown that the inhibition of rDNA transcription by PV can be demonstrated in vitro by using mock-and virus-infected cell extracts. By fractionation of mock-infected cell extracts, we were able to show that a partially purified fraction containing UBF and the species-specific SL-1 could restore pol I transcription in virus-infected cell extracts (Rubinstein et al., 1992 
METHODS
Cells and viruses. HeLa cells were maintained in Dulbecco's modified Eagle's medium containing 5 % newborn calf serum (NCS) and 5 % fetal calf serum. Cells were split in a 1 : 10 ratio in fresh medium every 3 days. HeLa suspension cells were grown in minimum essential medium (Sigma) with 5 % NCS at 37 uC with constant stirring. Cells were re-inoculated into fresh medium every 3 days at a ratio of 1 : 5 to 1 : 10. Cells were infected with PV type 1 (Mahoney strain) at an m.o.i. of 20, as described previously (Clark et al., 1991; Rubinstein et al., 1992) .
In vitro transcription/translation and protease assays. In vitro coupled transcription and translation in the presence of [ 35 S]methionine were performed with the TNT Quick Coupled Transcription/Translation system (Promega) as described previously (Yalamanchili et al., 1996) . In a 25 ml reaction volume, 20 ml TNT master mix, 10 mCi (370 kBq) [ 35 S]methionine and 1 mg plasmid DNA were added. Reactions were carried out at 30 uC for 90 min. One microlitre of this reaction mixture was digested with 1 mg purified 3C
pro for 3-4 h at 30 uC in a 10 ml reaction volume, as described previously (Yalamanchili et al., 1996) . The reaction mixture also contained 20 mM HEPES, 100 mM NaCl, 1 mM EDTA and 1 mM dithiothreitol (DTT). Control reactions were incubated for the same time, but without 3C pro . Products were separated by SDS-PAGE, fixed and detected by fluorography.
Pol I transcription assay. Specific transcription assays were performed basically as described by Tower et al. (1986) . The 25 ml reaction mixture contained a final concentration of 80 mM KCl, 5 mM MgCl 2 , 10 mM HEPES pH 7?9, 1 mM DTT, 0?1 mM EDTA, 500 mM each of ATP, CTP and GTP, 5-10 mCi (185-370 kBq) [a 32 P]UTP [specific activity, 3000 Ci (111 TBq) mmol 21 ], 100 mg aamanitin ml 21 , 2?5 mg rDNA template pUCHU3 ml 21 (Rubinstein & Dasgupta, 1989) and 50-60 mg mock-or PV-infected transcription extracts. The template was truncated with BamHI so that correct initiation of transcription at the promoter produced a 1500 nt run-off transcript. Reaction mixtures were incubated at 30 uC for 1 h. The reactions were then terminated and RNA was isolated, denatured with glyoxal and DMSO, electrophoresed on 1?4 % agarose gels and autoradiographed as described by Manley et al. (1983) .
Plasmid constructs. The plasmid prHU 3 was kindly provided by R. Tjian (Learned & Tjian, 1982) . The complete 2?0 kb EcoRIBamHI insert, which includes the transcription-initiation region of a human rRNA gene, was subcloned into pUC18 between the EcoRI and BamHI sites for greater plasmid yields. The two templates, prHU 3 and pUCHU 3 , were found to be equivalent in directing in vitro transcription. The cDNA clones that encode TAF 110 , TAF 63 and TAF 48 have been reported previously (Comai et al., 1992) .
Pol I, UBF and SL-1 purification. Pol I used in the reconstituted transcription reaction was prepared from HeLa cells. Nuclear extracts were loaded on a heparin-agarose column and the proteins were eluted with a salt gradient from 0?1 to 0?7 M KCl. Fractions eluted at 250 mM KCl were pooled, dialysed against TM buffer [50 mM Tris/HCl (pH 7?9), 12?5 mM MgCl 2 , 1 mM EDTA, 20 % glycerol] containing 0?1 M KCl and fractionated on a Sepharose 300 (Pharmacia Biotech) gel-filtration column. Active fractions were then loaded onto a Q-Sepharose column (Poros HQ) equilibrated with TM buffer containing 0?1 M KCl. Proteins were eluted with a salt gradient from 0?1 to 0?7 M KCl in TM buffer. The active fractions were pooled, dialysed to 0?125 M KCl, aliquotted and stored at 280 uC. This pol I preparation contained no detectable UBF or SL-1 activity. The human UBF and SL-1 proteins were purified as described previously (Bell et al., 1988; Comai et al., 1992; Zhai et al., 1997) . The purity of UBF and SL-1 preparations was checked by 10 % SDS-PAGE followed by silver staining.
RESULTS
Both SL-1 and UBF are required to restore rDNA transcription in PV-infected cell extracts Previous studies from our laboratory have shown that the inhibition of host-cell transcription by RNA polymerases observed in PV-infected HeLa cell extracts could be rescued by partially purified pol I transcription factors (Rubinstein & Dasgupta, 1989; Rubinstein et al., 1992) . We used a similar approach to examine whether purified pol I factors could restore transcription from an rDNA template containing a human pol I promoter in PV-infected extracts. Both SL-1 and UBF were purified as described previously (Bell et al., 1988; Comai et al., 1992) . Whilst purified UBF showed mainly one major polypeptide at approximately 97 kDa, purified SL-1 consisted of four major polypeptides with approximate molecular masses of 110, 63, 48 and 38 kDa (Fig. 1a , lanes 1 and 2). A polypeptide migrating slightly faster than TAF 63 appeared to be a contaminant that co-purified with the SL-1 complex (Fig. 1a, lane 2) . The 38 kDa polypeptide co-migrated with purified human TBP (Fig. 1a, lane 3) . The purified factors were examined in an in vitro transcription assay (Rubinstein & Dasgupta, 1989) . As shown in Fig. 1(b) , accurate transcription from the rDNA template containing a human pol I promoter required pol I, SL-1 and UBF (lane 4). Omission of any of the three proteins in the reaction resulted in a dramatic decrease in transcription (Fig. 1b, lanes 1-3) . Thus, there was very little, if any, cross-contamination between the three protein preparations. SL-1, but not UBF, was found to be present in limiting quantities in mock-infected extracts, as transcription in mock extracts was stimulated significantly by SL-1 compared with UBF (Fig. 1c, lanes 1-3) . Transcription from the human rDNA promoter was stimulated 5?2-fold over the control in mock-infected cell extracts in the presence of both factors (Fig. 1b, lanes 1 and 4) . We then examined whether purified SL-1 and UBF could restore pol I transcription from the rDNA template in PV-infected cell extracts. Both SL-1 and UBF-1 stimulated pol I transcription to some extent when added to PV-infected transcription extracts individually; however, neither purified SL-1 nor UBF was able to restore pol I transcription completely in PV-infected extracts (Fig. 1c , lanes 6 and 7). In the presence of both factors, transcription in infected extract was restored almost to the level seen in mock-infected extracts (Fig. 1c , compare lanes 4 and 8). The high-molecular-mass transcript seen in PV-infected extracts is PV RNA, which results from elongation of pre-initiated viral RNA present in the infected extract and is visualized due to incorporation of labelled UMP by the PV RNA-dependent RNA polymerase during the pol I transcription run-off assay (Rubinstein & Dasgupta, 1989) . The purified pol I could not restore pol I transcription in PV-infected extracts, suggesting that the transcriptional activity of pol I in HeLa cells was not affected by PV infection (Fig. 1d) . These results suggested that transcriptional activity of both SL-1 and UBF was compromised in PV-infected cells.
SL-1 is cleaved by 3C
pro in vitro SL-1 is composed of TBP and three TAFs with molecular masses of 105/110, 63 and 48 kDa ( Fig. 2a) . By using in vitro-translated TAF proteins and purified 3C pro , we were able to show that TAF 110 was cleaved by 3C pro into four main fragments with approximate molecular masses of 95, 65, 26 and 8 kDa (Fig. 2c, lanes 1 and 2; Fig. 3b To determine whether all of the proteolytic cleavage products of TAF 110 were produced at the same time following incubation with 3C pro or whether the cleavages were sequential, a time-course analysis of TAF 110 cleavage by 3C pro was performed. As shown in Fig. 3(b) , there was no significant cleavage of TAF 110 after a 15 min incubation with 3C pro (Fig. 3b, lane 2) . After 30 min, two TAF 110 cleavage products with molecular masses of 95 and 8 kDa were apparent (Fig. 3b, lane 3) . Two additional proteolytic products with molecular masses of 65 and 26 kDa were detected after a 60 min incubation (Fig. 3b, lane 4) . The intensities of the 65, 26 and 8 kDa products increased after 90 and 120 min incubation with 3C pro (Fig. 3b , lanes 5 and 6). The intensity of full-length TAF 110 reduced significantly, starting at 60 min, and almost all full-length TAF 110 disappeared by 120 min, concomitant with the increased generation of the 65, 26 and 8 kDa proteolytic products. The intensity of the 95 kDa polypeptide did not change significantly at later time points compared with full-length TAF 110 . Increasing the incubation time to 4 h did not change the intensity of the 3C pro -digested products significantly compared with the 2 h time point (data not shown). UBF and SL-1 were purified from HeLa cells as described previously (Comai et al., 1992) . Purified UBF (lane 1), SL-1 (lane 2) and TBP (lane 3) were analysed by SDS-PAGE (10 % gel) followed by silver staining. (b) Reconstitution of in vitro transcription by RNA polymerase I. Approximately 75 ng each of purified UBF and SL-1 and 500 ng purified RNA pol I were used in the in vitro transcription assay using the pUCHU 3 rDNA template. Transcription was carried out in the presence of all three components (lane 4), pol I and SL-1 (lane 1), pol I and UBF (lane 2) or SL-1 and UBF (lane 3). (c) Transcription from a human rDNA template (pUCHU 3 ) was performed as described in Methods. S100 extract (50 mg) prepared at 4 h p.i. from mock-infected (lanes 1-4) and PV-infected (lanes 5-8) HeLa cells was used in the transcription assay in the absence (lanes 1 and 5) (lane 4). Labelled products were analysed by SDS-PAGE followed by autoradiography as described in Methods. Examination of the primary sequence of TAF 110 (aa 1-869) revealed that it contained six glutamine-glycine (QG) sites at positions 265, 277, 414, 510, 737 and 805 ( Fig. 3a ; Comai et al., 1994) . Because PV 3C pro preferentially cleaves glutamine-glycine sites in the viral precursor polypeptides, we wished to determine which QG sites were cleaved by 3C pro in the in vitro proteolysis assay. The six QG sites were mutated individually by substituting the Q residue with alanine. Previous studies have shown that substitution of the Q residue (of the QG bond) with alanine blocks 3C promediated cleavage of both viral precursor proteins and transcription factor TBP (Krausslich & Wimmer, 1988; Das & Dasgupta, 1993) . Alteration of the QG sites at positions 277, 414, 510 and 737 did not change the TAF 110 cleavage pattern by 3C pro compared with the wt protein, suggesting that these sites were not cleaved by 3C
pro to generate the four polypeptides (Fig. 3c, lanes 1-6, 11 , 12, 15 and 16). In contrast, 3C
pro -mediated generation of the 26 kDa product was inhibited completely by the Q 265 A mutation (Fig. 3c , lanes 9 and 10). Additionally, the intensity of the 65 kDa polypeptide was reduced significantly in the Q
265
A mutant compared with wt TAF 110 (Fig. 3c, compare lanes 8 and 10) . Similarly, the Q 805 A mutation inhibited formation of the 95, 65 and 8 kDa proteolysed products (Fig. 3c, lanes 13 and  14) . The intensity of the 26 kDa product was also reduced to some extent in the Q 805 A mutant (lane 14). The Q 805 A mutation appeared to change the conformation of TAF 110 , which apparently induced cleavage at an alternative site, as evidenced by the appearance of two new proteolysis products of 100 and 85 kDa (Fig. 3c, lanes 13 and 14, indicated by dots). Mutating both the Q 265 and Q 805 sites resulted in total disappearance of the 95, 65, 26 and 8 kDa polypeptides (Fig. 3c, lanes 17 and 18) . However, the generation of the two polypeptides of 100 and 85 kDa was still evident in the double mutant, as seen earlier with the Q 805 A single mutant. These results suggested that proteolytic cleavage by 3C pro primarily at the QG sites at positions 265 and 805 leads to the generation of the four proteolytic products of TAF 110 that are seen in vitro.
Both SL-1 and UBF are modified in PV-infected cells
Cell-free transcription extracts prepared from HeLa cells at 0, 1, 2, 3 and 4 h p.i. were used to transcribe a human rDNA template in a run-off transcription assay. Analysis of labelled transcripts showed that rDNA transcription was not inhibited significantly up to 2 h p.i. (Fig. 4a, lanes 1-3) . At 3 h p.i., rDNA transcription was inhibited approximately fourfold compared with the control (lane 4). No pol I transcript was detectable at 4 h p.i. (Fig. 4a, lane 5) . To assess whether TAF 110 was cleaved in PV-infected cells, transcription extracts prepared from PV-infected cells at 0, 1, 2, 3 and 4 h p.i. were examined by Western blot analysis using a polyclonal antibody against TAF 110 (Comai et al., 1992) . The antibody recognized a polypeptide migrating at 105/ 110 kDa and an additional 80 kDa polypeptide at 0 h p.i. (Fig. 4b, lane 1) . The 110 kDa polypeptide co-migrated with purified TAF 110 in the Western blot (Fig. 4b, compare lanes  1 and 6) . Both the 110 and 80 kDa polypeptides disappeared between 3 and 4 h p.i. (Fig. 4b, lanes 4 and 5) . Despite repeated attempts, we were unable to detect the TAF 110 proteolytic products in PV-infected cells. This suggested 
that 3C
pro cleavage products were either not recognized by the TAF 110 antibody or that the proteolytic products were degraded quickly in infected cells.
Previous results from our laboratory have shown that purified recombinant UBF and in vitro-translated, [
35 S]methionine-labelled UBF are not cleaved by purified 3C pro in vitro (Rubinstein et al., 1992) , suggesting that UBF might not be a target for PV 3C pro or that the in vitrotranslated UBF was not modified properly. However, our transcription analysis in PV-infected extracts showed that UBF was required for full restoration of pol I transcription in the presence of SL-1 (Fig. 1) . We therefore examined whether UBF was being modified by PV infection. The level of UBF was examined by Western blot analysis of the same extracts, as shown in Fig. 4(a) . Two forms of UBF were detected at 0 h p.i., as well as up to 2 h p.i. (Fig. 4c, lanes  1-3) . These two UBF-specific bands co-migrated with purified UBF (Fig. 4c, lane 6) . At 3 h p.i., both bands were reduced, with a concomitant increase in one predominant, faster-migrating band with a molecular mass of approximately 78 kDa (Fig. 4c, lane 4) . The intensity of UBF was further reduced at 4 h p.i., with the appearance of another faster-migrating band at~52 kDa in addition to the 78 kDa polypeptide (Fig. 4c, lane 5) . These results suggested that, although UBF is not cleaved by 3C pro in vitro, it is modified in PV-infected cells.
DISCUSSION
PV inhibits transcription mediated by all three cellular RNA polymerases in the nuclei of infected cells, a phenomenon known as shut-off of host-cell transcription. We have presented evidence here that suggests that both pol I transcription factors, SL-1 and UBF, are modified and inactivated during infection of HeLa cells with PV. Neither purified SL-1 nor UBF was able to restore pol I transcription fully from an rDNA promoter in PV-infected extracts. However, both factors were necessary to restore transcription in infected extract to the level seen in mock-infected extracts (Fig. 1) . The significant stimulation of rDNA transcription seen in mock-infected extract in the presence of both UBF and SL-1 appeared to be due mainly to SL-1 (Fig. 1) . This suggested that SL-1, but not UBF, is limiting in mock-infected HeLa cells. In contrast, although both UBF and SL-1 appeared to stimulate pol I transcription individually in PV-infected cell extracts, complete restoration of transcription clearly required the presence of both factors.
Our results suggested that both UBF and SL-1 are almost completely depleted in PV-infected cells at 4 h p.i. (Fig. 4) . Therefore, adding UBF or SL-1 alone into the PV-infected (4 h) transcription extract should not stimulate transcription. Results presented in Fig. 1(c) , however, showed that the background transcription in PV-infected extract was somewhat stimulated by the addition of either UBF (Fig. 1c,  lane 6 ) or SL-1 (Fig. 1c, lane 7) compared with that in mockinfected extract (Fig. 1c, lane 1) . The precise reason for this is not known and could be due to differential sensitivity of the two assays -transcription and Western blotting -used here. Low levels of UBF and SL-1, not detectable by Western blotting, could still be present in the infected extracts, which could be responsible for the stimulation of transcription observed in the presence of exogenously added individual factors. The in vitro transcription assay, which uses incorporation of high-specific-activity [ 32 P]-labelled UTP, is likely to be much more sensitive than the Western blot analysis. Additionally, the presence of limiting concentrations of SL-1 in mock-infected extract could also be partly responsible for this discrepancy.
The multi-subunit protein SL-1 consists of TBP and three TAFs (TAF 110 , TAF 63 and TAF 48 ). Results presented in Fig. 2 (Fig. 3a) . Secondly, the Q 805 A mutation inhibited the formation of the 95 and 8 kDa products almost completely (Fig. 3c, lane 14) . In addition, the Q 805 A mutation appeared to induce a conformational change in TAF 110 , possibly exposing other sites in the protein that could be cleaved by 3C
pro to generate two new polypeptides of 100 and 85 kDa (Fig. 3c , lanes 13-14 and 17-18). However, these two polypeptides were not seen in the 3C pro cleavage assay with the wt TAF 110 polypeptide and appeared to be due to the Q 805 A mutationinduced change in the protein structure.
The 26 kDa (predicted molecular mass,~30 kDa) proteolysis product first appeared after 1 h incubation with 3C pro (Fig. 3b, lane 4) . The 26 kDa product was probably generated by 3C pro -mediated cleavage at the Q 265 G 266 bond, as the Q 265 A mutation almost completely blocked formation of the 26 kDa product (Fig. 3c, lane 10) .
The 65 kDa polypeptide could be generated from full-length TAF 110 by cleavage at the Q 805 G 806 and Q 265 G 266 sites. Alternatively, it could also result from cleavage of the 95 kDa polypeptide at the Q 265 G 266 site (Fig. 3a) . The appearance of the 65 kDa band did not correlate with a concomitant reduction in the intensity of the 95 kDa product, but did correlate with reduction in intensity of the full-length TAF 110 polypeptide, suggesting that it was generated from TAF 110 by cleavage at the Q 805 G 806 and Q 265 G 266 sites (Fig. 3b, lanes 4-6) (Fig. 3c, lanes 17  and 18) . However, although the intensity of the 65 kDa polypeptide was decreased significantly by the Q 265 G mutation, it was not eliminated (Fig. 3c, 
PV 3C
pro has been shown to prefer glutamine at P1 and either glycine or alanine or serine at P19 for cleavage of viral precursor polypeptides (Dewalt et al., 1989; Kean et al., 1990) . In addition, aliphatic amino acids (such as alanine, valine or isoleucine) at P4 are preferred for 3C/3CD-mediated cleavage between P1 and P19 (Blair & Semler, 1991; Harris et al., 1992 Previous studies from our laboratory have shown that inhibition of pol I transcription is first detected at 3 h p.i. with PV (Rubinstein & Dasgupta, 1989) . Results presented in Fig. 4 suggest that this inhibition could be due to degradation of UBF (Fig. 4c) . Both UBF-specific bands seen in the immunoblot appear to be cleaved at 3 h p.i. Our previous data have shown that both in vitro-translated and bacterially expressed UBF are totally resistant to cleavage by purified 3C pro or 2A pro in vitro (Rubinstein et al., 1992) . This suggests that the in vitro-translated/bacterially expressed UBF is not modified properly to undergo cleavage by the viral proteases. Alternatively, one or more host-cell factors may be required along with viral protease (3C or 2A) for UBF cleavage in vivo. PV-induced degradation of the tumour suppressor p53 requires both 3C
pro and host-cell proteins (Weidman et al., 2001) . In contrast to UBF cleavage, the TAF 110 polypeptide appeared to be degraded at 4 h p.i. (Fig. 4b) . Despite repeated attempts, we were unable to detect specific proteolytic fragments of TAF 110 in PVinfected cells. This could be due to rapid degradation of the fragments in infected cells. A similar phenomenon has previously been reported for p53 (Weidman et al., 2001) . The p53 protein is degraded rapidly soon after infection of HeLa cells with PV. It is also possible that the antibody did not recognize the proteolytic fragments of TAF 110 , although this is unlikely as we used a polyclonal antibody to TAF 110 . Although the proteolytic fragments of TAF 110 could not be detected in PV-infected cells, the fact that a mutant PV with a point mutation in the 3C pro -coding sequence is unable to shut off pol I transcription efficiently in vivo (Weidman et al., 2003) suggests the involvement of 3C pro in pol I transcription shut-off.
Recent results from our laboratory have shown that the viral 3C pro enters the nucleus in PV-infected cells in the form of the polymerase-protease precursor 3CD (Sharma et al., 2004) . We believe that autocatalysis of 3CD in the nucleus generates 3C
pro , which consequently cleaves SL-1/UBF, leading to pol I transcription shut-off. Alternatively, it is possible that 3CD, but not 3C, could be responsible for UBF cleavage in the nucleus. Future in vitro studies will be directed towards understanding the role of 3CD in UBF cleavage.
An intriguing observation in our studies was that TBP, a component of SL-1, was unable to restore pol I transcription in PV-infected cell extracts (data not shown). TBP plays a crucial role in the form of TFIID (TBP plus pol II TAFs) in RNA polymerase II-mediated transcription. Although TBP cleavage by 3C pro is the major cause of inhibition of RNA pol II-mediated transcription in PV-infected cells (Clark et al., 1993) , it appeared to have no significant effect on pol I transcription rescue in PV-infected extracts. This suggests that TBP in the SL-1 complex might be resistant to cleavage by 3C pro . Perhaps the association of pol I TAFs with TBP somehow protects it from 3C pro cleavage, whilst in TFIID, the pol II TAFs are unable to protect TBP from 3C pro cleavage. Future studies on the susceptibility of TBP in the TFIID and SL-1 complexes to 3C pro cleavage should shed light on the organization of these multiprotein complexes. Although TBP does not appear to rescue pol I transcription in PV-infected extracts, we cannot completely rule out the possibility that TBP is not involved in pol I shut-off, as recombinant TBP added to a cell extract may not incorporate into a functionally active SL-1 complex.
In summary, we have provided evidence suggesting that the pol I factors SL-1 and UBF are modified in PV-infected HeLa cells, leading to transcriptional inactivation of these factors. It is highly likely that the inactivation of these two factors contributes to the shut-off of cellular pol I transcription observed in PV-infected cells. 
